News for Pacific Biosciences of California, Inc. (PACB)

PacBio (PACB) and Target ALS have embarked on an ambitious project to conduct the most extensive whole genome sequencing initiative for ALS to date. Utilizing P

PacBio (PACB) has announced a strategic partnership with Haorui Gene, a prominent authority in the field of blood typing genomics, to act as its official distri

In a recent analysis, Piper Sandler has maintained its "Neutral" rating for Pacific Biosciences (PACB). This decision comes alongside a notable adjustment in th

Piper Sandler has revised its price target for Pacific Biosciences (PACB), lowering it from $2 to $1.25 after the company released its latest quarterly earnings

Pacific Biosciences (PACB) has wrapped up an independent investigation conducted by a Special Committee of its Board of Directors into allegations concerning em

May 08, 2025 / 08:30PM GMTOperator Good afternoon, everyone, and welcome to the PacBio first quarter-2025 earnings conference call. (Operator Instructions) Ther

Key Takeaways: Pacific Biosciences (PACB) meets Q1 2025 revenue expectations with $37.2 million. Analysts forecast a strong potential upside of 70.49%, w

The following slide deck was published by Pacific Biosciences of California, Inc.

MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio ( PACB) today announced financial results for the quarter ended March 31, 2025. First quarter res

The volume of options for Pacific Biosciences of California (PACB) has surged to 1.5 times its usual level prior to the company's earnings report. In this activ

ARK ETFs sold 376,874 Palantir (PLTR) shares for $46.65 million, continuing a week-long reduction, while investing $10.45 million in 237,374 Guardant Health (GH) shares, signaling a shift from data analytics to precision oncology. Significant purchases included $10.17 million for 283,186 Twist Bioscience (TWST) shares and $8.75 million for 55,623 Natera…

PacBio (PACB) has embarked on a groundbreaking initiative by partnering to integrate its HiFi whole genome sequencing (WGS) technology into a newborn screening

On Wednesday, April 30, 2025, Cathie Wood sold $2.65 million worth of Palantir shares through various ARK ETFs.

Pacific Biosciences, known by its stock ticker PACB, has announced plans to enhance its methylation detection capabilities through a licensing agreement with Th

In recent analyst actions, Bernstein's Eve Burstein has adjusted the firm's price target for PacBio (PACB), reducing it from $2 to $1.50. However, the firm main

U.S. stocks were higher, with the Dow Jones index surging over 300 points on Wednesday. Shares of The Simply Good Foods Company SMPL rose sharply during Wednes...

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.

We recently compiled a list of the 10 Most Volatile Stocks Under $3 For Day Trading. In this article, we are going to take a look at where Pacific Biosciences of California, Inc.